Median Diagnostics (XKRX:233250) EV-to-FCF : 42.60 (As of Apr. 24, 2025)

Median Diagnostics EV-to-FCF Chart

Median Diagnostics Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-FCF		Get a 7-Day Free Trial					61.75	21.43	-19.88	64.80	40.52

Median Diagnostics Semi-Annual Data
	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-FCF	Get a 7-Day Free Trial					61.75	21.43	-19.88	64.80	40.52

Competitive Comparison of Median Diagnostics's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Median Diagnostics's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Median Diagnostics's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Median Diagnostics's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Median Diagnostics's EV-to-FCF falls into.

Median Diagnostics EV-to-FCF Calculation

Median Diagnostics's EV-to-FCF for today is calculated as:

Median Diagnostics's current Enterprise Value is ₩16,635 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Median Diagnostics's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was ₩391 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Median Diagnostics  (XKRX:233250) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Median Diagnostics's PE Ratio (TTM) for today is calculated as:

Median Diagnostics's share price for today is ₩14990.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Median Diagnostics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩730.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Median Diagnostics EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Median Diagnostics's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Median Diagnostics Business Description